Sabinsa Defends Tetrahydrocurcuminoids Patent With Legal Action

July 6, 2016

Sabinsa Corporation manufactures and markets phytonutrients, Ayurvedic herbal extracts and specialty fine chemicals for nutritional, pharmaceutical and food industries. Sabinsa has carved a niche for itself by its extensive research support for its customers and products, and the scientific credentials of its key technical staff. Founded in 1988 by Muhammed Majeed, Ph.D., Sabinsa is a company dedicated to the principles of tradition, innovation and research. Sabinsa's efforts have begun to earn the company vast recognition, in addition to growing sales.

East Windsor, N.J. (July 6, 2016) – Sabinsa Corp. has filed lawsuits in the United States District Court, District of New Jersey, against four dietary supplement ingredient companies for making, selling, and/or importing products that infringe upon Sabinsa’s Tetrahydrocurcuminoid Patent covering compositions and methods of using tetrahydrocurcuminoids in the US. The companies are: Olive Lifesciences Pvt. Ltd. (Bangalore, India), Nachurel Ingredients LLC (North Brunswick, NJ), Chemill Inc. (Bothell, WA), and Aegle Bios Inc. (Edison, NJ). Both Olive and Nachurel were named in a previous suit for infringement on another of Sabinsa’s patents.

The issued U.S. Patent No. 6,653,327, on the compositions and uses of tumeric-derived tetrahydrocurcuminoids is public knowledge, as is Sabinsa’s stated intent to protect the company’s intellectual property.  

“We are determined to protect our intellectual property when our patents are infringed upon. These defendants’ customers are also infringing upon Sabinsa’s patents, most likely without their knowledge, so these infringing companies are putting their customer’s businesses at risk,” said Sabinsa founder Muhammed Majeed PhD. “We have been very outspoken in calling on industry manufacturers to respect intellectual property; to do otherwise both stifles innovation and does a disservice to those manufacturers who legitimately license intellectual property.”

“Sabinsa's patent claims compositions and methods of using its tetrahydrocurcuminoid compositions” stated James H. Hulme, Esquire of Arent Fox LLP in Washington, DC, who represents Sabinsa in this matter. “Sabinsa will enforce its patent rights and protect its intellectual property to the fullest extent allowed by law,” he explained.

Sabinsa’s patent covers compositional claims and also several topical and oral applications of tetrahydrocurcuminoids noted for their high anti-oxidant capacity.

About Sabinsa Corporation:

Sabinsa Logo Since 1988

Sabinsa's mission is to provide alternative and complementary natural products for human nutrition and well-being. Over the past 27 years, Sabinsa has brought to market more than 100 standardized botanical extracts, and privately funded clinical studies in conjunction with prestigious institutions in support of these products. With more than 100 full-time scientists conducting ongoing research in India and the United States, Sabinsa and parent company Sami Labs Ltd. continue to develop, patent and manufacture phytonutrients for the world market, with ingredients that are both Halal and Kosher. For more information, visit